DCGI asked to stop over-the-counter sale of nicotine gums by the Delhi government

  • News
  • December 24, 2017

The Delhi government’s health department sent written request to the Drug Controller General of India (DGCI) to stop the over-the-counter sale of nicotine gums and lozenges without an authorized prescription. Dr. SK Arora in a letter addressing Dr. GN Singh, additional director (Health) said nicotine have potential addiction property and people can use like a drug in the form of gums and lozenges which were being sold at medical shops over the counter without any prescription.

During counseling, motivation and behavioral therapy, People addicted to a small percentage of moderate tobacco users may require these drugs as nicotine replacement therapy (NRT) under the supervision of qualified counsellors. But the selling of these drugs over the counter without any prescription promotes malpractices and self-therapy, it may lead to merely shifting the person from one addiction to another, the letter read.

Dr. Arora said the youngsters who can’t use tobacco products directly due to social or family fear may easily use them, s they should stop selling over counters.

  • Related Posts

    Centre Pushes Haryana to Fast-Track AIIMS Rewari

    New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

    Rajasthan Drops 1,114 Hospitals From RGHS in Fraud Drive

    Jaipur, August 18, 2025 — Rajasthan has removed 1,114 private hospitals from the Rajasthan Government Health Scheme (RGHS) after a statewide fraud sweep. The Health Department also suspended 1,901 healthcare…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses

    HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses

    Eli Lilly launches cancer drug Tanstrive in India

    Eli Lilly launches cancer drug Tanstrive in India

    Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals

    Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals

    Centre eases BIS quality compliance with new risk-based framework for manufacturers

    Centre eases BIS quality compliance with new risk-based framework for manufacturers

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    ‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility

    ‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility